Le réacteur Jules Horowitz et la production de radio-isotopes artificiels

Abstract

The Jules Horowitz reactor (JHR) is a major project in Europe aimed at securing the supply of medical radioisotopes (with a commitment on the molybdenium-99 production: from 25% to 50% of the European needs) and supporting nuclear research (offering fuel and material experiments). It will be capable of producing a wide range of radioisotopes (thanks to dedicated equipment and tools), including molybdenum-99, essential for nuclear medicine. It will also be able to produce lutetium-177 and other isotopes used in therapy and diagnostics. The reactor is expected to be operational between 2032 and 2034.